Price
$165.68+2.16%Social Signal Score
Company Profile
- Sector
- Financial Services
- Industry
- Asset Management
- Beta
- 0.51
- Country
- US
Quote
Valuation & Ratios
Returns & Efficiency
Valuation
XLVhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
50+0.00%Social Signal Score
Mentions (16)
- News (RSS)fool·11d ago·Neutral
XLV vs IBB: How Healthcare Diversification Compares to Biotech Concentration XLV offers exposure to the broader healthcare sector, while IBB targets biotech innovators. Here's how the two stack up on risk, returns, and diversification.
View source ↗ - News (RSS)fool·12d ago·Positive
XLV vs. PJP: How Broad Healthcare Diversification Stacks Up to Pharma Stocks XLV's broader diversification and lower fees appeal to cost-conscious investors, while PJP's concentrated pharma bet has outperformed over the past year.
View source ↗ - Newsfool.com·12d ago·Negative
XLV vs. PJP: How Broad Healthcare Diversification Stacks Up to Pharma Stocks The State Street Health Care Select Sector SPDR ETF (XLV) offers significantly lower ownership costs, with an expense ratio of 0.08% compared to 0.58% for the Invesco Pharmaceuticals ETF (PJP). PJP provides concentrated exposure to 28 pharmaceutical stocks, while XLV holds 61 diversified healthcare companies.
View source ↗ - News (RSS)yahoo·22d ago·Neutral
State Street XLV vs. iShares IXJ: Here's How These Healthcare ETFs Stack Up for Investors
View source ↗ - News (RSS)fool·22d ago·Neutral
State Street XLV vs. iShares IXJ: Here's How These Healthcare ETFs Stack Up for Investors XLV's 0.08% expense ratio and 22.7% 1-year return outpace IXJ's global reach, but international diversification comes at a cost.
View source ↗ - Newsfool.com·22d ago·Negative
State Street XLV vs. iShares IXJ: Here's How These Healthcare ETFs Stack Up for Investors XLV has a significantly lower expense ratio of 0.08% compared to IXJ's 0.38%. IXJ provides broader exposure with 110 holdings across global markets, while XLV concentrates on 60 domestic S&P 500 stocks.
View source ↗ - Newsetftrends.com·25d ago·Negative
Blend Innovative Growth & Defense With Healthcare ETFs All too often, when investors look at the healthcare sector, they mostly see its value for its defensive merits. However, that view may be shortsighted and miss the broader picture in today's market.
View source ↗ - Newsfool.com·29d ago·Positive
If the Fed Hikes Interest Rates This Month, History Says This Is the Smartest ETF to Buy Right Now The State Street Health Care Select Sector SPDR ETF could be a rising rates winner. It easily outpaced the broader market when the Fed hiked rates in 2022.
View source ↗ - 4chan /biz/biz·31d ago·Neutral
thinking about just parking all my money in healthcare stocks like XLV. apparently they go up 100% of time during midterms
View source ↗ - Newsfxempire.com·32d ago·Positive
XLV, XLK and MOO Forecast: Agriculture ETF Breaks Out MOO has recently broken out and is showing real momentum, while XLV continues its uptrend and XLK holds around the 50-day EMA. The agriculture ETF carries the strongest bullish outlook of the three.
View source ↗ - Newszacks.com·41d ago·Neutral
Should You Invest in the State Street Health Care Select Sector SPDR ETF ETF (XLV)? If you're interested in broad exposure to the Healthcare - Broad segment of the equity market, look no further than the State Street Health Care Select Sector SPDR ETF ETF (XLV), a passively managed exchange traded fund launched on December 16, 1998.
View source ↗ - Newsseekingalpha.com·43d ago·Positive
Healthcare Is Rising: XLV Is A Better Option For Investors Than BME BlackRock Health Sciences Trust (BME) has recently outperformed due to a narrowing NAV discount, not superior portfolio management. XLV, the passive healthcare ETF, has consistently delivered higher total returns and better NAV preservation than BME over 5- and 10-year periods. BME's recent strategy shift away from call options to capital gains distributions has not produced positive alpha relative to XLV.
View source ↗ - Newszacks.com·47d ago·Positive
Healthcare ETFs Are Looking Up: Here's Why Healthcare ETFs are hitting 52-week highs as earnings improve, dealmaking accelerates, FDA approvals stay strong and investors seek defensive growth.
View source ↗ - PodcastCompound And Friends·52d ago·Neutral
… get a drug approved or not approved, it could mean 30% market cap. - Yeah, instantly. - I think that's also why sector investing needs to evolve. You can't just buy XLV or XOI, because industrial is a super diverse, right? You might transport you buying power generation. - So it's already-- - Or airplanes or Uber. - So you're seeing more, not necessarily niche, but sub-sector ETFs launch. - The Madex. - It's the Madex. And that's the kind of-- - The sector is a very artificial. They come from t…
View source ↗ - Newsfool.com·58d ago·Neutral
Vanguard Health Care ETF vs State Street XLV: Which ETF Is the Better Buy for Investors in 2026? Vanguard Health Care ETF offers much broader diversification with 411 holdings compared to the 60 stocks in State Street Health Care Select Sector SPDR ETF. State Street Health Care Select Sector SPDR ETF is slightly more cost-effective with an expense ratio of 0.08% versus 0.09% for the Vanguard fund.
View source ↗ - 4chan /biz/biz·65d ago·Neutral
>>62549875 XLV
View source ↗
Congress trades
- Thomas Hawley Tubervillesenate · AL · disclosed Aug 5, 2026 (231d later)Buy$15,001 - $50,000
- Thomas Hawley Tubervillesenate · AL · disclosed Jan 15, 2026 (29d later)Buy$15,001 - $50,000
- Chuck Fleischmannhouse · TN03 · disclosed Feb 13, 2023 (21d later)Sell$1,001 - $15,000
- Kurt Schraderhouse · OR05 · disclosed May 17, 2022 (39d later)Buy$1,001 - $15,000
- Chuck Fleischmannhouse · TN03 · disclosed Feb 11, 2022 (18d later)Buy$1,001 - $15,000
- Kurt Schraderhouse · OR05 · disclosed Dec 23, 2020 (30d later)Sell$1,001 - $15,000
- Patrick Joseph Toomeysenate · PA · disclosed Dec 20, 2017 (1055d later)Buy$1,001 - $15,000
- Patrick Joseph Toomeysenate · PA · disclosed Mar 23, 2015 (52d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.